• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reader Response: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.

作者信息

Feng Qian

机构信息

(Suzhou, China).

出版信息

Neurology. 2023 Oct 17;101(16):728-729. doi: 10.1212/WNL.0000000000207889.

DOI:10.1212/WNL.0000000000207889
PMID:37845047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10585668/
Abstract
摘要

相似文献

1
Reader Response: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.读者回应：口服抗凝剂与非瓣膜性心房颤动患者的痴呆风险：一项基于人群的队列研究
Neurology. 2023 Oct 17;101(16):728-729. doi: 10.1212/WNL.0000000000207889.
2
Author Response: Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.作者回应：口服抗凝剂与非瓣膜性心房颤动患者的痴呆风险：一项基于人群的队列研究。
Neurology. 2023 Oct 17;101(16):729. doi: 10.1212/WNL.0000000000207890.
3
Efficacy and safety of novel oral anticoagulants in patients with atrial nonvalvular atrial fibrillation and diabetes mellitus: a systematic review and meta-analysis.新型口服抗凝剂在非瓣膜性心房颤动合并糖尿病患者中的疗效和安全性：系统评价和荟萃分析。
J Transl Med. 2022 Sep 30;20(1):441. doi: 10.1186/s12967-022-03652-9.
4
Comparative effectiveness and safety of rivaroxaban with other oral anticoagulants in older adults with nonvalvular atrial fibrillation: population-based analysis in response to updated Beers Criteria.利伐沙班与其他口服抗凝剂在老年非瓣膜性心房颤动患者中的疗效及安全性比较：基于人群的分析以回应更新的Beers标准
J Thromb Haemost. 2025 Feb;23(2):546-555. doi: 10.1016/j.jtha.2024.10.009. Epub 2024 Oct 21.
5
Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.非瓣膜性心房颤动患者预防卒中的阿司匹林、华法林和新型抗凝药的混合治疗比较荟萃分析。
Clin Ther. 2013 Jul;35(7):967-984.e2. doi: 10.1016/j.clinthera.2013.05.011.
6
Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.新型口服抗凝剂（达比加群、利伐沙班、阿哌沙班）与华法林治疗心房颤动患者的疗效和安全性的荟萃分析。
Am J Cardiol. 2012 Aug 1;110(3):453-60. doi: 10.1016/j.amjcard.2012.03.049. Epub 2012 Apr 24.
7
Dabigatran Versus Warfarin for Atrial Fibrillation in Real-World Clinical Practice: A Systematic Review and Meta-Analysis.达比加群与华法林用于真实世界临床实践中房颤治疗的系统评价与Meta分析
Circ Cardiovasc Qual Outcomes. 2016 Mar;9(2):126-34. doi: 10.1161/CIRCOUTCOMES.115.002369. Epub 2016 Jan 26.
8
Relative efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation by network meta-analysis.通过网状Meta分析评估直接口服抗凝剂在心房颤动患者中的相对疗效和安全性。
J Cardiovasc Med (Hagerstown). 2014 Dec;15(12):873-9. doi: 10.2459/JCM.0000000000000206.
9
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.口服抗凝药预防心房颤动患者卒中：系统评价、网状Meta分析及成本效益分析
BMJ. 2017 Nov 28;359:j5058. doi: 10.1136/bmj.j5058.
10
Cost-effectiveness of new oral anticoagulants compared with warfarin in preventing stroke and other cardiovascular events in patients with atrial fibrillation.新型口服抗凝剂与华法林预防房颤患者中风和其他心血管事件的成本效益比较。
Value Health. 2013 Jun;16(4):498-506. doi: 10.1016/j.jval.2013.01.009. Epub 2013 Apr 23.

本文引用的文献

1
Oral Anticoagulants and the Risk of Dementia in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Cohort Study.口服抗凝剂与非瓣膜性心房颤动患者痴呆风险：一项基于人群的队列研究。
Neurology. 2023 Mar 21;100(12):e1309-e1320. doi: 10.1212/WNL.0000000000206748. Epub 2022 Dec 29.